Amerikaanse aandelen « Terug naar discussie overzicht

Amyris

244 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 12 13 » | Laatste
nobahamas
0
Amyris & Kuraray Deliver Superior Performance in Sumitomo's Dunlop Winter Maxx 02 Car Tires Driving Accelerated Growth for Amyris
investors.amyris.com/releasedetail.cf...
[verwijderd]
0
nb
0
DeZwarteRidder
0
According to the complaint, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California's affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris' decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
DeZwarteRidder
0
quote:

DeZwarteRidder schreef op 30 april 2017 10:03:

According to the complaint, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California's affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris' decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
Nobahamas is nu eenmaal gek op 'scam-aandelen'.

Iedereen die hem volgt had dat kunnen weten.
DeZwarteRidder
0
PR Newswire•yesterday
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc.

NEW YORK, April 28, 2017 /PRNewswire/ -- Amyris, Inc. (AMRS) Lifshitz & Miller announces investigation on behalf of AMRS investors after AMRS reported a $10 million decrease in revenue from March 2, 2017 ...
---------------------
PR Newswire•2 days ago
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, Calif., April 28, 2017 /PRNewswire/ -- Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (AMRS). Investors who purchased or otherwise acquired shares between March 2, 2017 and April 17, 2017 inclusive (the "Class Period"), are encouraged to contact the Firm in advance of the June 19, 2017 lead plaintiff motion deadline. If you purchased Amyris shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
---------------------------
Accesswire•2 days ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amyris, Inc. - AMRS

NEW YORK, NY / ACCESSWIRE / April 28, 2017 / Levi & Korsinsky, LLP announces it has commenced an investigation of Amyris, Inc. (NASDAQ: AMRS) concerning possible breaches of fiduciary duty. To obtain additional ...
-----------------------
Accesswire•2 days ago
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 27, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") ...
------------------------
PR Newswire•2 days ago
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm

NEW YORK, April 27, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amyris, Inc. ("Amyris" or the "Company") (AMRS) of the June 19, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. The lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all those who purchased Amyris securities between March 2, 2017 and April 17, 2017, (the "Class Period"). The case, OHREN v. Amyris, Inc. et al., No. 3:17-cv-02210 was filed on April 20, 2017.
-------------------------
Business Wire•3 days ago
AMRS LOSS NOTICE: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important Deadline in First Filed Class Action – AMRS

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Amyris, Inc. securities from March 2, 2017 through April 17, 2017, both dates inclusive of the important June 19, 2017 lead plaintiff deadline in the first filed class action commenced by the Rosen Law Firm.
---------------------------
GlobeNewswire•3 days ago
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Amyris, Inc. (Nasdaq: AMRS) To Contact Brower Piven Before The Lead Plaintiff Deadline

STEVENSON, Md., April 26, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ...
-----------------------
Accesswire•3 days ago
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / April 26, 2017 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: ...
---------------------------
GlobeNewswire•3 days ago
IMPORTANT AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Amyris, Inc.

NEW YORK, April 26, 2017-- Wolf Haldenstein Adler Freeman & Herz LLP announces that a filing class action lawsuit has been filed in the United States District Court for the Northern District of California ...
------------------------
Business Wire•4 days ago
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Amyris, Inc. concerning possible violations of federal securities laws.
News
--------------------------
Accesswire•4 days ago
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Amyris, Inc. (AMRS) and Lead Plaintiff Deadline: June 19, 2017

NEW YORK, NY / ACCESSWIRE / April 26, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amyris, Inc. ("Amyris" or the "Company") ...
---------------------------
News
Business Wire•5 days ago
SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Amyris, Inc.

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. . Investors who purchased shares between March 2, 2017 and April 17, 2017 inclusive , are encouraged to contact the firm in advance of the June 19, 2017 lead plaintiff motion deadline.
News
---------------------------
Business Wire•5 days ago
Robbins Arroyo LLP Is Investigating the Officers and Directors of Amyris, Inc. (AMRS) on Behalf of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Amyris, Inc. violated federal securities laws by issuing materially false and misleading statements regarding the company's business and operations.
--------------------------
News
Business Wire•6 days ago
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP announces the filing of a class action lawsuit against Amyris, Inc. . Investors who purchased or otherwise acquired shares between March 2, 2017 and April 17, 2017 inclusive , are encouraged to contact the Firm in advance of the June 19, 2017 lead plaintiff motion deadline.
------------------------
News
PR Newswire•6 days ago
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Amyris, Inc. (AMRS) & Lead Plaintiff Deadline: June 19, 2017

NEW YORK, April 24, 2017 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amyris, Inc. ("Amyris" ...
News
Capital Cube•6 days ago
[verwijderd]
0
DeZwarteRidder
0
Amyris is een belachelijk bedrijf: bij een brutowinst van ca 3 miljoen, wordt er ca 100 miljoen uitgegeven aan research en verkoopkosten.
Ook hebben ze ca 175 miljoen lange schuld.

De koers is trouwens gedaald van ruim 30 USD naar ca 50 cent.
haas
0
quote:

nobahamas schreef op 9 juni 2015 18:00:

Mooie tijd om in te stappen?

Amyris & Ipca Laboratories Ltd. Sign Letter of Intent for Development and Supply of Active Pharmaceutical Ingredients

www.benzinga.com/news/15/06/5579197/a...

-/- 85% in 3 jaren tijd,vanaf 11-4-2014
[verwijderd]
0
[verwijderd]
0
Misschien erg dom van mij maar ik zit er nog in op 0,61 per aandeel
Ik voel potentie, maar onderbouwen kan ik het niet
[verwijderd]
0
finance.yahoo.com/news/royal-dsm-equi...

Gelukkig ben ik op tijd uit Amyris gestapt, want vandaag is de koers met ruim 30% gezakt.

Toch heb ik de neiging om nu weer in te stappen omdat DSM voor lange termijn gaat investeren in Amyris. Lees Yahoo Finance
nb
0
dat is toch best gek, ja.
Je kunt het bericht ook gewoon lezen op actueel of bij DSM
ik denk een pluk aan te schaffen
[verwijderd]
0
Ik heb een pluk gekocht op CAD 0,33
Er zit wel wat risico op. maar daar tegenover staat dat deze koers plotseling zomaar kan exploderen met 40 tot 80% winst.
Nooit geschoten is altijd mis.
Met DSM (niet de eerste de beste) heb ik toch een redelijk safe gevoel
244 Posts, Pagina: « 1 2 3 4 5 6 7 8 9 10 11 12 13 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
865,36  0,00  0,00%  18 apr
 Germany40^ 17.662,70 -0,98%
 BEL 20 3.826,58 0,00%
 Europe50^ 4.888,46 -0,97%
 US30^ 38.013,46 0,00%
 Nasd100^ 17.548,80 0,00%
 US500^ 5.049,25 0,00%
 Japan225^ 38.001,71 0,00%
 Gold spot 2.380,95 +0,07%
 EUR/USD 1,0633 -0,10%
 WTI 83,29 +1,47%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

AALBERTS NV 0,00%
ABN AMRO BANK... 0,00%
Accsys 0,00%
ACOMO 0,00%
ADYEN NV 0,00%

Dalers

AALBERTS NV 0,00%
ABN AMRO BANK... 0,00%
Accsys 0,00%
ACOMO 0,00%
ADYEN NV 0,00%

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront